Therapeutics for cardiovascular diseases


Exit 2012

Corimmun develops peptides and human proteins for the treatment of cardiovascular diseases, especially heart failure. The main focus is dilated cardiomyopathy (DCM) and the regeneration of arteriosclerotic vascular lesions including proliferative vascular changes.

MIG invests in Corimmun 2008
Exit 2012
Back to portfolio